A critical examination of translational medicine, when private risk is transferred to the public sector and university research teams become tech startups for global investors.
prečítať celé
A critical examination of translational medicine, when private risk is transferred to the public sector and university research teams become tech startups for global investors.
Skryť popis
Recenzie